EcoDrugPlus

Matrix Metallopeptidase 8

Ensembl ID : ENSBMSG00010006829
Gene Symbol: MMP8
1 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSBMSG00010021389
Gene Symbol: MMP9
1 Cross references
216 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSBMSG00010014863
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSBMSG00010017331
Gene Symbol: MC3R
1 Cross references
139 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSBMSG00010012174
Gene Symbol: MC4R
1 Cross references
229 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSBMSG00010008461
Gene Symbol: MTNR1B
1 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSBMSG00010002306
Gene Symbol: MME
1 Cross references
234 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSBMSG00010009403
Gene Symbol: METAP2
1 Cross references
230 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSBMSG00010014569
Gene Symbol: MAPK1
1 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSBMSG00010002157
Gene Symbol: MAPK10
1 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSBMSG00010020151
Gene Symbol: MAPK11
1 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSBMSG00010011729
Gene Symbol: MAPK14
1 Cross references
293 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).